These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 5050051

  • 1. [Characteristics of the psychotropic activity of long-acting drugs (experience in the use of Moditen-depot)].
    Smulevich AB, Minsker EI, Mazaeva NA, Volkova RP, Lukanina SK.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):912-20. PubMed ID: 5050051
    [No Abstract] [Full Text] [Related]

  • 2. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice.
    Faltus F.
    Act Nerv Super (Praha); 1974 Aug; 16(3):167-8. PubMed ID: 4607824
    [No Abstract] [Full Text] [Related]

  • 3. [Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
    Tsutsul'kovskaia MIa, Minsker EI, Panteleeva GP, Mazurskii MB, Pekunova LG.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973 Aug; 73(5):753-8. PubMed ID: 4718619
    [No Abstract] [Full Text] [Related]

  • 4. Maintenance treatment of schizophrenia with long-acting fluphenazine.
    Niturad A, Ciurezu T, Cucu I.
    Act Nerv Super (Praha); 1974 Aug; 16(3):167. PubMed ID: 4154028
    [No Abstract] [Full Text] [Related]

  • 5. Long acting phenothiazines and long term psychotic patients: the role of fluphenazine enanthate in treatment.
    Wintrob RM.
    Dis Nerv Syst; 1970 Sep; 31():Suppl:50-62. PubMed ID: 4990944
    [No Abstract] [Full Text] [Related]

  • 6. [Long-term moditen-depot treatment of schizophrenic patients at a psychoneurology dispensary].
    Abramova LI, Gushanskiĭ EL.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986 Sep; 86(3):419-24. PubMed ID: 3705854
    [Abstract] [Full Text] [Related]

  • 7. The depot fluphenazines: a reappraisal after 10 years' clinical experience.
    Ayd FJ.
    Am J Psychiatry; 1975 May; 132(5):491-500. PubMed ID: 1091162
    [No Abstract] [Full Text] [Related]

  • 8. Side effects of depot fluphenazines.
    Ayd FJ.
    Adv Biochem Psychopharmacol; 1974 May; 9(0):301-9. PubMed ID: 4599435
    [No Abstract] [Full Text] [Related]

  • 9. Extrapyramidal symptoms in the course of fluphenazine treatment.
    Bastecký J, Vinar O, Taussigová D.
    Act Nerv Super (Praha); 1972 May; 14(2):97-9. PubMed ID: 5040184
    [No Abstract] [Full Text] [Related]

  • 10. Our experience with Moditene-Depot in chronic schizophrenia.
    Gamkrelidze ShA, Putkoradze-Gamkrelidze NA.
    Act Nerv Super (Praha); 1973 Aug; 15(3):169. PubMed ID: 4769133
    [No Abstract] [Full Text] [Related]

  • 11. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
    Haumonté MT, Hoerdt HP.
    Ann Med Psychol (Paris); 1972 Feb; 1(2):277-83. PubMed ID: 5051257
    [No Abstract] [Full Text] [Related]

  • 12. Long acting peroral fluphenazine and its dosage in psychoses.
    Vinar O, Taussigová D, Bastecký J, Boleloucký Z.
    Act Nerv Super (Praha); 1970 Feb; 12(3):248-9. PubMed ID: 4917583
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of moditen-depot therapy on the duration and quality of remissions in schizophrenia patients].
    Vovin RIa, Gurovich IIa, Eryshev OF, Zaĭtsev SG, Magalif AIu.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977 Feb; 77(5):743-9. PubMed ID: 899478
    [Abstract] [Full Text] [Related]

  • 14. [Comparative study of the therapeutic effectiveness of mirenil prolongatum and moditen depot in the treatment of schizophrenia].
    Afeltowicz Z, Sep-Kowalikowa B, Zgirski L.
    Psychiatr Pol; 1976 Feb; 10(5):479-85. PubMed ID: 981421
    [No Abstract] [Full Text] [Related]

  • 15. [Experience with the depot neuroleptic LyogenR-depot].
    Bach O, Petermann H, Geppert V.
    Psychiatr Neurol Med Psychol (Leipz); 1978 Sep; 30(9):563-6. PubMed ID: 733993
    [Abstract] [Full Text] [Related]

  • 16. [Considerations on the use of long-acting neuroleptics in a mental health center].
    Carotti P, Merli R.
    Minerva Med; 1986 Sep 15; 77(34-35):1577-83. PubMed ID: 2876402
    [Abstract] [Full Text] [Related]

  • 17. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
    Auch W.
    Med Welt; 1970 Oct 10; 21(41):1785-8. PubMed ID: 5471981
    [No Abstract] [Full Text] [Related]

  • 18. [Long-acting neuroleptic preparations and their use in mental disorders].
    Vovin RIa, Vovina EN.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972 Oct 10; 72(6):920-4. PubMed ID: 5050052
    [No Abstract] [Full Text] [Related]

  • 19. [Experience with depot neuroleptics].
    Arató M, Erdós A.
    Orv Hetil; 1979 Apr 29; 120(17):1015-21. PubMed ID: 372888
    [No Abstract] [Full Text] [Related]

  • 20. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.
    Levine J, Schooler NR, Severe J, Escobar J, Gelenberg A, Mandel M, Sovner R, Steinbook R.
    Adv Biochem Psychopharmacol; 1980 Apr 29; 24():483-93. PubMed ID: 6996445
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.